Mitochondrial disorders in the nervous system

Annual Review of Neuroscience

Volumn 31, Issue , 2008, Pages 91-123

  DiMauro, Salvatore ^a   Schon, Eric A ^a  

^a Department of Medicine   (United States)

Author keywords

Aging; Apoptosis; Maternal inheritance; Mitochondrial DNA; Oxidative phosphorylation; Oxidative stress

Indexed keywords

MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN DISEASE; CLINICAL FEATURE; CODING; DEGENERATIVE DISEASE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXTRACHROMOSOMAL INHERITANCE; FRIEDREICH ATAXIA; GENE DELETION; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HETEROPLASMY; HUMAN; HUNTINGTON CHOREA; MITOCHONDRIAL GENETICS; MITOCHONDRION; MOLECULAR DYNAMICS; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TRANSPORT; PSYCHIATRY; RESPIRATORY CHAIN; REVIEW; RNA TRANSLATION;

ANIMALS; BRAIN DISEASES, METABOLIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS;

EID: 48249156188     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.neuro.30.051606.094302     Document Type: Review

References (176)

1. Alam R, Hachiya N, Sakaguchi M, Kawabata S, Iwanaga S, et al. 1994. cDNA cloning and characterization of mitochondrial import stimulation factor (MSF) purified from rat liver cytosol. J. Biochem. 116:416-25
2. Alexander C, Votruba M, Pesch UEA, Thiselton DL, Mayer S, et al. 2000. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26:211-15
3. Anandatheerthavarada HK, Biswas G, Robin MA, Avadhani NG. 2003. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell. Biol. 161:41-54
4. Anderson S, Bankier AT, Barrel BG, DeBruijn M, Coulson AR, et al. 1981. Sequence and organization of the human mitochondrial genome. Nature 290:457-65
5. Ankarcrona M, Hultenby K. 2002. Presenilin-1 is located in rat mitochondria. Biochem. Biophys. Res. Commun. 295:766-70
6. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, et al. 1999. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons. J. Cell Biol. 147:277-94
7. Azari NP, Pettigrew KD, Schapiro MB, Haxby JV, Grady CL, et al. 1993. Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data. J. Cereb. Blood Flow Metab. 13:438-47
8. Beal MF. 2005. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58:495-505
9. Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, et al. 2006. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat. Genet. 38:515-17
10. Betts J, Jaros E, Perry RH, Schaefer AM, Taylor RW, et al. 2006. Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement. Neuropath. Appl. Neurobiol. 32:359-73
11. Bonilla E, Tanji K, Hirano M, Vu TH, DiMauro S, Schon EA. 1999. Mitochondrial involvement in Alzheimer's disease. Biochim. Biophys. Acta 1410:171-82
12. Borthwick GM, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. 1999. Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann. Neurol. 46:787-90
13. Bossy-Wetzel E, Barsoum MJ, Godzik A, Schwartzenbacher R, Lipton SA. 2003. Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr. Opin. Cell Biol. 15:706-16
14. Bourdon A, Minai L, Serre V, Jais J-P, Sarzi E, et al. 2007. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat. Genet. 39:776-80
15. Brandon NJ, Schurov I, Camargo LM, Handford EJ, Duran-Jimeniz B, et al. 2005. Subcellular targeting of DISC1 is dependent on a domain independent from the Nudel binding site. Mol. Cell. Neurosci. 28:613-24
16. Bykhovskaya Y, Casas KA, Mengesha E, Inbal A, Fischel-Ghodsian N. 2004. Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am. J. Hum. Genet. 74:1303-8
17. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, et al. 2004. The Parkinsons disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. USA 101:9103-8
18. Carelli V, Achilli A, Valentino ML, Rengo C, Semino O, et al. 2006. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am. J. Hum. Genet. 78:564-74
19. Carelli V, La Morgia C, Iommarini L, Carroccia R, Mattiazzi M, et al. 2007. Mitochondrial optic neuropathies: how two genomes may kill the same cell type? Biosci. Rep. 27:173-84
20. Casari G, De Fusco M, Ciarmatori S, Zeviani M, Mora M, et al. 1998. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973-83
21. Casley CS, Canevari L, Land JM, Clark JB, Sharpe MA. 2002. β-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80:91-100
22. Chacinska A, Rehling P. 2004. Moving proteins from the cytosol into mitochondria. Biochem. Soc. Trans. 32:774-76
23. Chan DC. 2006. Mitochondria: dynamic organelles in disease, aging, and development. Cell 125:1241-52
24. Chantrel-Groussard K, Geromel V, Puccio H, Koenig M, Munnich A, et al. 2001. Disabled early recruitment of antioxidant defenses in Friedreich's ataxia. Hum. Mol. Genet. 10:2061-67
25. Chaudhri M, Scarabel M, Aitken A. 2003. Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. Biochem. Biophys. Res. Commun. 300:679-85
26. Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M. 2004. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13:1407-20
27. Chung KW, Kim SB, Park KD, Choi KG, Lee JH, et al. 2006. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Brain 129:2103-18
28. Cipolat S, Martins de Brito O, Dal Zilio B, Scorrano L. 2004. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl. Acad. Sci. USA 101:15927-32
29. Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, et al. 2006. Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126:163-75
30. Claypool SM, McCaffrey JM, Koehler CM. 2006. Mitochondrial mislocalization and altered assembly of cluster of Barth syndrome mutant tafazzins. J. Cell Biol. 174:379-90
31. Coenen MJH, Antonicka H, Ugalde C, Sasarman F, Rossi P, et al. 2004. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. New Engl. J. Med. 351:2080-86
32. Comi GP, Bordoni A, Salani S, Franceschina L, Sciacco M, et al. 1998. Cytochrome c oxidase subunit I microdeletion in a patient with motor neuron disease. Ann. Neurol. 43:110-16
33. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-23
34. Darios F, Corti O, Lucking CB, Hampe C, Muriel M-P, et al. 2003. Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12:517-26
35. Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, et al. 2006. Early-onset familial parkinsonism due to POLG mutations. Ann. Neurol. 59:859-62
36. Delettre C, Lenaers G, Griffoin J-M, Gigarel N, Lorenzo C, et al. 2000. Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat. Genet. 26:207-10
37. De Meirleir L, Seneca S, Lissens W, De Clercq I, Eyskens F, et al. 2004. Respiratory chain complex V deficiency due to a mutation in the assembly gene ATP12. J. Med. Genet. 41:120-24
38. De Strooper B. 2003. Aph-1, Pen-2, and nicastrin with presenilin generate an active γ-secretase complex. Neuron 38:9-12
39. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK. 2006. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J. Neurosci. 26:9057-68
40. DiMauro S, Davidzon G. 2005. Mitochondrial DNA and disease. Ann. Med. 37:222-32
41. DiMauro S, Davidzon G, Hirano M. 2006a. A polymorphic polymerase. Brain 126:1637-39
42. DiMauro S, Hirano M. 2005. Mitochondrial encephalomyopathies: an update. Neuromusc. Disord. 15:276-86
43. DiMauro S, Hirano M, Kaufmann P, Mann JJ. 2006b. Mitochondrial psychiatry. In Mitochondrial Medicine, ed. S DiMauro, M Hirano, EA Schon, pp. 261-77. London: Informa Healthcare
44. DiMauro S, Hirano M, Schon EA. 2006c. Approaches to the treatment of mitochondrial diseases. Muscle Nerve 34:265-83
45. DiMauro S, Quinzii C, Hirano M. 2007. Mutations in coenzyme Q10 biosynthetic genes. J. Clin. Invest. 117:587-89
46. DiMauro S, Schon EA. 2003. Mitochondrial respiratory-chain diseases. New Engl. J. Med. 348:2656-68
47. Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, et al. 2005. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomy-opathy and mitochondrial DNA depletion. Am. J. Hum. Genet. 76:1081-86
48. Engelender S, Sharp AH, Colomer V, Tokito MK, Lanahan A, et al. 1997. Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum. Mol. Genet. 6:2205-12
49. Fenton WA. 1995. Mitochondrial protein transport: a system in search of mutations. Am. J. Hum. Genet. 57:235-38
50. Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M. 2006. Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anemia (MLASA). J. Med. Genet. 44:173-80
51. Fichera M, Lo Giudice M, Falco M, Sturnio M, Amata A, et al. 2004. Evidence of kinesin heavy chain (KIF5A) involvement in pure hereditary spastic paraplegia. Neurology 63:1108-10
52. Gabriel K, Milenkovic D, Chacinska A, Muller J, Guiard B, et al. 2006. Novel mitochondrial intermembrane space proteins as substrates of the MIA import pathway. J. Mol. Biol. 365:612-20
53. Gempel K, Topaloglu H, Talim B, Schneiderat P, Schoser BGH, et al. 2007. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene. Brain 130:2037-44
54. Goedert M, Spillantini MG. 2006. A century of Alzheimer's disease. Science 314:777-81
55. Gohil VM, Hayes P, Matsuyama S, Schagger H, Schlame M, Greenberg ML. 2004. Cardiolipin biosynthesis and mitochondrial respiratory chain function are interdependent. J. Biol. Chem. 279:42612-18
56. Greenamyre JT. 2007. Huntington's Disease - making connections. New Engl. J. Med. 356:518-20
57. Gutekunst CA, Li SH, Yi H, Ferrante RJ, Li XJ, Hersch SM. 1998. The cellular and subcellular localization of huntingtin-associated protein 1 (HAP1): comparison with huntingtin in rat and human. J. Neurosci. 18:7674-86
58. Hansen JJ, Durr A, Cournu-Rebeix I, Georgopoulos C, Ang D, et al. 2002. Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet. 70:1328-32
59. Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, et al. 2004. Nicastrin, presenilin, APH-1, and PEN-2 form active γ-secretase complexes in mitochondria. J. Biol. Chem. 279:51654-60
60. Harding AE. 1992. Growing old: the most common mitochondrial disease of all? Nat. Genet. 2:251-52
61. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A. 2006. Genetics of Parkinson's disease and parkinsonism. Ann. Neurol. 60:389-98
62. Harman D. 1972. The biologic clock: the mitochondria? J. Am. Geriat. Soc. 20:145-47
63. Haut S, Brivet M, Touati G, Rustin P, Lebon S, et al. 2003. A deletion in the human QP-C gene causes a complex III deficiency resulting in hypoglycaemia and lactic acidosis. Hum. Genet. 113:118-22
64. Hays AP, Oskoui M, Tanji K, Kaufmann P, Bonilla E. 2006. Mitochondrial neurology II: myopathies and peripheral neuropathies. In Mitochondrial Medicine, ed. S DiMauro, M Hirano, EA Schon, pp. 45-74. London: Informa Healthcare
65. Hirano M, Kaufmann P, De Vivo DC, Tanji K. 2006a. Mitochondrial neurology I: Encephalopathies. In Mitochondrial Medicine, ed. S DiMauro, M Hirano, EA Schon, pp. 27-44. London: Informa Healthcare
66. Hirano M, Lagier-Tourenne C, Valentino ML, Marti R, Nishigaki Y. 2005. Thymidine phosphorylase mutations cause instability of mitochondrial DNA. Gene 354:152-56
67. Hirano M, Marti R, Casali C, Tadesse BS, Uldrick T, et al. 2006b. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458-60
68. Holt IJ, Harding AE, Morgan Hughes JA. 1988. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717-19
69. Honda T, Nihonmatsu N, Yasutake K, Ohtake A, Sato K, et al. 2000. Familial Alzheimer's disease-associated mutations block translocation of full-length presenilin 1 to the nuclear envelope. Neurosci. Res. 37:101-11
70. Hudson G, Keers S, Yu Wai Man P, Griffiths P, Huoponen K, et al. 2005. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am. J. Hum. Genet. 77:1086-91
71. Ikuta J, Maturana A, Fujita T, Okajima T, Tatematsu K, et al. 2007. Fasciculation and elongation protein zeta-1 (FEZ1) participates in the polarization of hippocampal neuron by controlling the mitochondrial motility. Biochem. Biophys. Res. Commun. 353:127-32
72. James R, Adams RR, Christie S, Buchanan SR, Porteous DJ, Millar JK. 2004. Disrupted in schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol. Cell. Neurosci. 26:112-22
73. Kakiuchi C, Ishiwata M, Kametani M, Nelson C, Iwamoto K, Kato T. 2005. Quantitative analysis of mitochondrial DNA deletions in the brains of patients with bipolar disorder and schizophrenia. Int. J. Neuropharmacol. 8:1-8
74. Kakiuchi C, Iwamoto K, Ishiwata M, Bundo M, Kasahara T, et al. 2003. Impaired feedback regulation of XBP1 as a genetic risk factor for bipolar disorder. Nat. Genet. 35:171-75
75. Karadimas CL, Vu TH, Holve SA, Quinzii C, Tanji K, et al. 2006. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am. J. Hum. Genet. 79:544-48
76. Kato T, Ishiwata M, Mori K, Washizuka S, Tajima O, et al. 2002. Mechanisms of altered calcium signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropharmacol. 6:379-89
77. Kaufmann P, Sano MC, Jhung S, Engelstadt K, De Vivo DC. 2002. Psychiatric symptoms are common features of clinical syndromes associated with mitochondrial DNA point mutations. Neurology 58:A315 (Abstract)
78. Kaufmann P, Shungu D, Sano MC, Jhung S, Engelstad K, et al. 2004. Cerebral lactic acidosis correlates with neurological impairment in MELAS. Neurology 62:1297-302
79. Khrapko K, Kraytsberg Y, de Grey ADNJ, Vijg J, Schon EA. 2006. Does premature aging of the mtDNA mutator mouse prove that mtDNA mutations are involved in natural aging? Aging Cell 5:279-82
80. Kins S, Lauther N, Szodorai A, Beyreuther K. 2006. Subcellular trafficking of the amyloid precursor protein gene family and its pathogenic role in Alzheimer's disease. Neurodegen. Dis. 3:218-26
81. Kirby DM, Boneh A, Chow CW, Ohtake A, Ryan MT, et al. 2003. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann. Neurol. 54:473-78
82. Kirk R, Furlong RA, Amos W, Cooper G, Rubinsztein JS, et al. 1999. Mitochondrial genetic analyses suggest selection against maternal lineages in bipolar affective disorder. Am. J. Hum. Genet. 65:508-18
83. Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, et al. 1992. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:776-79
84. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. 2004. Molecular evidence for mitochondrial dysfunction in bipolar disease. Arch. Gen. Psychiat. 61:300-8
85. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K. 2006. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet. 38:518-20
86. Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, et al. 2005. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 309:481-84
87. Lawson VH, Graham BV, Flanigan KM. 2005. Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene. Neurology 65:197-204
88. Ledley FD, Jansen R, Nham SU, Fenton WA, Rosenberg LE. 1990. Mutation eliminating mitochondrial leader sequence of methylmalonyl-CoA mutase causes mut° methylmalonic acidemia. Proc. Natl. Acad. Sci. USA 87:3147-50
89. Li J, Lee WL, Cooper JA. 2005. NudEL targets dynein to microtubule ends through LIS1. Nat. Cell Biol. 7:686-90
90. Li SH, Gutekunst CA, Hersch SM, Li XJ. 1998. Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 18:1261-69
91. Liu JK, Lillo C, Jonsson PA, Velde CV, Ward CM, et al. 2004. Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron 43:5-17
92. Longley MJ, Clark S, Man CYW, Hudson G, Durham SE, et al. 2006. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am. J. Hum. Genet. 78:1026-34
93. López LC, Quinzii C, Schuelke M, Kanki T, Naini A, et al. 2006. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations. Am. J. Hum. Genet. 79:1125-29
94. Lu J, Rashid F, Byrne PC. 2006. The hereditary spastic paraplegia protein spartin localises to mitochondria. J. Neurochem. 98:1908-19
95. Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, et al. 2004. ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease. Science 304:448-52
96. Maeda K, Nwulia E, Chang J, Balkissoon R, Ishizuka K, et al. 2006. Differential expression of disrupted-in-schizophrenia (DISC1) in bipolar disorder. Biol. Psych. 60:929-35
97. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH. 2006. Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. Hum. Mol. Genet. 15:1437-49
98. Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, et al. 2002. A presenilin-1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21:1948-56
99. Mastrogiacomo F, Bergeron C, Kish SJ. 1993. Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J. Neurochem. 61:2007-14
100. Mattson MP. 2004. Pathways towards and away from Alzheimer's disease. Nature 430:631-39
101. McDermott CJ, Grierson AJ, Wood JD, Bingley M, Wharton SB, et al. 2003. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann. Neurol. 54:748-59
102. Millar JK, James R, Christie S, Porteous DJ. 2005. Disrupted in schizophrenia 1 (DISC1): subcellular targeting and induction of ring mitochondria. Mol. Cell. Neurosci. 30:477-84
103. Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, et al. 2004. Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation. Ann. Neurol. 56:734-38
104. Mollet J, Giurgea I, Schlemmer D, Dallner G, Chretien D, et al. 2007. Prenyldiphosphate synthase (PDSS1) and OH-benzoate prenyltransferase (COQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. J. Clin. Invest. 117:765-72
105. Mootha VK, Lepage P, Miller K, Bunkenborg J, Reich M, et al. 2003. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc. Natl. Acad. Sci. USA 100:605-10
106. Morin C, Mitchell G, Larochelle J, Lambert M, Ogier H, et al. 1993. Clinical, metabolic, and genetic aspects of cytochrome c oxidase deficiency in Saguenay-Lac-Saint-Jean. Am. J. Hum. Genet. 53:488-96
107. Muftuoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, et al. 2003. Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov. Disord. 19:544-48
108. Naviaux RK, Nguyen KV. 2004. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann. Neurol. 55:706-12
109. Newmeyer DD, Ferguson-Miller S. 2003. Mitochondria: releasing power for life and unleashing the machinery of death. Cell 112:481-90
110. Niemann A, Ruegg M, La Padula V, Schenone A, Suter U. 2005. Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease. J. Cell Biol. 170:1067-78
111. Nishino I, Spinazzola A, Hirano M. 1999. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689-92
112. Nolden M, Ehses S, Koppen M, Bernacchia A, Rugarli EI, Langer T. 2005. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 123:277-89
113. Ogilvie I, Kennaway NG, Shoubridge EA. 2005. A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J. Clin. Invest. 115:2784-92
114. Pallotti F, Chen X, Bonilla E, Schon EA. 1996. Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging. Am. J. Hum. Genet. 59:591-602
115. Pedrola L, Espert A, Wu X, Claramunt R, Shy ME, Palau F. 2005. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum. Mol. Genet. 14:1087-94
116. Pellegrini L, Scorrano L. 2007. A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis. Cell Death Differ. 14:1275-84
117. Petit A, Kawarai T, Paitel E, Sanjo N, Maj M, et al. 2005. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson disease-related mutations. J. Biol. Chem. 280:34025-32
118. Pigino G, Morfini G, Pelsman A, Mattson MP, Brady ST, Busciglio J. 2003. Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport. J. Neurosci. 23:4499-508
119. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. 1997. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276:2045-47
120. Quinzii C, Kattah AG, Naini A, Akman HO, Mootha VK, et al. 2005. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64:539-41
121. Quinzii C, Naini A, Salviati L, Trevisson E, Navas P, et al. 2006. A mutation in parahydoxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency. Am. J. Hum. Genet. 78:345-49
122. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, et al. 2007. Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model. Science 316:750-54
123. Roberts RC. 2007. Schizophrenia in translation: disrupted in schizophrenia (DISC1I): integrating clinical and basic findings. Schizophr. Bull. 33:11-15
124. Roesch K, Curran SP, Tranebjaerg L, Koehler CM. 2002. Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex. Hum. Mol. Genet. 11:477-86
125. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, et al. 2007. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39:168-77
126. Rowland LP. 1994. Mitochondrial encephalomyopathies: lumping, splitting, and melding. In Mitochondrial Disorders in Neurology, ed. AHV Schapira, S DiMauro, pp. 116-29. Oxford: Butterworth-Heinemann
127. Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, et al. 2002. Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J. Neurosci. 22:1679-89
128. Sanderson CM, Connell JW, Edwards TL, Bright NA, Duley S, et al. 2006. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Hum. Mol. Genet. 15:307-18
129. Sarzi E, Brown MD, Lebon S, Chretien D, Munnich A, et al. 2007. A novel mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia. Am. J. Med. Genet. 143A:33-41
130. Schindler CK, Heverin M, Henshall DC. 2006. Isoform- and subcellular fraction-specific differences in hippocampal 14-3-3 levels following experimentally evoked seizures and in human temporal lobe epilepsy. J. Neurochem. 99:561-69
131. Schlame M, Ren M. 2006. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett. 580:5450-55
132. Schon EA. 2007. Appendix 5. Gene products present in mitochondria of yeast and animal cells. Meth. Cell Biol. 80:835-76
133. Schon EA, Rizzuto R, Moraes CT, Nakase H, Zeviani M, DiMauro S. 1989. A direct repeat is a hotspot for large-scale deletions of human mitochondrial DNA. Science 244:346-49
134. Schulz JB, Dehmer T, Schols L, Hardt C, Vorgerd M, et al. 2000. Oxidative stress in patients with Friedreich ataxia. Neurology 55:1719-21
135. Schwarzman AL, Singh N, Tsiper M, Gregori L, Dranovsky A, et al. 1999. Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc. Natl. Acad. Sci. USA 96:7932-37
136. Sedlak E, Panda M, Dale MP, Weintraub ST, Robinson NC. 2006. Photolabeling of cardiolipin binding subunits within bovine heart cytochrome c oxidase. Biochemistry 45:746-54
137. Seznec H, Simon D, Bouton C, Reutenauer L, Hertzog A, et al. 2005. Friedreich ataxia: the oxidative stress paradox. Hum. Mol. Genet. 14:463-74
138. Shapira Y, Harel S, Russell A. 1977. Mitochondrial encephalomyopathies: a group of neuromuscular disorders with defects in oxidative metabolism. Isr. J. Med. Sci. 13:161-64
139. Sheu KF, Kim YT, Blass JP, Weksler ME. 1985. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain. Ann. Neurol. 17:444-49
140. Shults CW, Schapira AHV. 2001. A cue to queue for CoQ? Neurology 57:375-76
141. Silvestri L, Caputo V, Bellacchio E, Atorino L, Dallapiccola B, et al. 2005. Mitochondrial import and enzymatic activity of PINK1 mutants associated with recessive parkinsonism. Hum. Mol. Genet. 14:3477-92
142. Siman R, Velji J. 2003. Localization of presenilin-nicastrin complexes and γ-secretase activity to the trans-Golgi network. J. Neurochem. 84:1143-53
143. Smeitink JAM, Elpeleg O, Antonicka H, Diepstra H, Saada A, et al. 2006. Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs. Am. J. Hum. Genet. 79:869-77
144. Soong NW, Hinton DR, Cortopassi G, Arnheim N. 1992. Mosaicism for a specific mitochondrial DNA mutation in adult human brain. Nat. Genet. 2:318-23
145. Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, D'Adamo P, et al. 2006. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat. Genet. 38:570-75
146. Spinazzola A, Zeviani M. 2005. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 354:162-68
147. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, et al. 1990. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336:13-16
148. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, et al. 2005. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307:1282-88
149. Strauss KM, Martins LM, Plun-Favreau H, Marx FP, Kautzmann S, et al. 2005. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14:2099-111
150. Sturtz LA, Diekert K, Jensen LT, Lill R, Culotta VC. 2001. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage. J. Biol. Chem. 276:38084-89
151. Takakubo F, Cartwright P, Hoogenraad N, Thorburn DR, Collins F, et al. 1995. An amino acid substitution in the pyruvate dehydrogenase E1αa gene, affecting mitochondrial import of the precursor protein. Am. J. Hum. Genet. 57:772-80
152. Tanji K, Kunimatsu T, Vu TH, Bonilla E. 2001. Neuropathological features of mitochondrial disorders. Cell Dev. Biol. 12:429-39
153. Tanji K, Schon EA, DiMauro S, Bonilla E. 2000. Kearns-Sayre syndrome: oncocytic transformation of choroid plexus epithelium. J. Neurol. Sci. 178:29-36
154. Tatuch Y, Christodoulou J, Feigenbaum A, Clarke J, Wherret J, et al. 1992. Heteroplasmic mtDNA mutation (T > G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am. J. Hum. Genet. 50:852-58
155. Taylor SW, Fahy E, Zhang B, Glenn GM, Warnock DE, et al. 2003. Characterization of the human heart mitochondrial proteome. Nat. Biotech. 21:281-86
156. Tieu K, Przedborski S. 2006. Mitochondrial dysfunction and neurodegenerative disorders. In Mitochondrial Medicine, ed. S DiMauro, M Hirano, EA Schon, pp. 279-307. London: Informa Healthcare
157. Tiranti V, Hoertnagel K, Carrozzo R, Galimberti C, Munaro M, et al. 1998. Mutations of SURF-1 in Leigh disease associated with cytochrome c oxidase deficiency. Am. J. Hum. Genet. 63:1609-21
158. Toyo-oka K, Shionoya A, Gambello MJ, Cardoso C, Leventer R, et al. 2003. 14-3-3ε is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat. Genet. 34:274-85
159. Trifunovic A, Wredenberg A, Falkenberg M, Spelbrink JN, Rovio AT, et al. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429:417-23
160. Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, et al. 2004. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 24:8195-209
161. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, et al. 2003. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc. Natl. Acad. Sci. USA 100:12171-76
162. Valente L, Tiranti V, Marsano RM, Malfatti E, Fernandez-Vizarra E, et al. 2007. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EGF1 and EFTu. Am. J. Hum. Genet. 80:44-58
163. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, et al. 2004. Association of γ-secretase with lipid rafts in post-Golgi and endosome membranes. J. Biol. Chem. 279:44945-54
164. Visapaa I, Fellman V, Vesa J, Dasvarma A, Hutton JL, et al. 2002. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am. J. Hum. Genet. 71:863-76
165. Wallace DC, Singh G, Lott MT, Hodge JA, Shurr TG, et al. 1988. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 242:1427-30
166. Wallace DC, Brown MD, Lott MT. 1999. Mitochondrial DNA variation in human evolution and disease. Gene 238:211-30
167. Walter J, Capell A, Grunberg J, Pesold B, Schindzielorz A, et al. 1996. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 2:673-91
168. Waterham HR, Koster J, van Roermund CWT, Mooyer PAW, Wanders RJA, Leonard JV. 2007. A lethal defect of mitochondrial and peroxisomal fission. New Engl. J. Med. 356:1736-41
169. Wiedemann FR, Manfredi G, Mawrin C, Beal MF, Schon EA. 2002. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients. J. Neurochem. 80:616-25
170. Wright AF, Jacobson SG, Cideciyan AV, Roman AJ, Shu X, et al. 2004. Lifespan and mitochondrial control of neurodegeneration. Nat. Genet. 36:1153-58
171. Zhang LS, Shimoji M, Thomas B, Moore D, Yu S-W, et al. 2005a. Mitochondrial localization of Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum. Mol. Genet. 14:2063-73
172. Zhang M, Mileykovskaya E, Dowhan W. 2005b. Cardiolipin is essential for organization of complexes III and IV into a supercomplex in intact yeast mitochondria. J. Biol. Chem. 280:29403-8
173. Zhu Z, Yao J, Johns T, Fu K, De Bie I, et al. 1998. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat. Genet. 20:337-43
174. Zuchner S, De Jonghe P, Jordanova A, Claeys KG, Guergueltcheva V, et al. 2006a. Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2. Ann. Neurol. 59:276-81
175. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, et al. 2004. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat. Genet. 36:449-51
176. Zuchner S, Wang G, Tran-Viet KN, Nance MA, Gaskell PC, et al. 2006b. Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am. J. Hum. Genet. 79:365-69